NIH-funded research NIH-funded research

Understanding the long-term effects of sarcoma treatment on survivors

Official title: CAUSAL: Cohort to Augment the Understanding of Sarcoma Survivorship Across the Lifespan

Funded at Vanderbilt University Medical Center · NIH-10933537 · Data updated 2026-11-12

This study is looking for sarcoma survivors to join a group that will help us learn more about their long-term health, including how their treatments and lifestyle choices affect their recovery and quality of life, so we can improve care for future patients.

More Sarcoma research and trials

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionVanderbilt University Medical Center
NIH-funded
Lab location1 site (Nashville, United States)
Project startSeptember 22, 2021
Project endAugust 31, 2027
Funding year2024
Award (this year)$2,243,832
NIH project number5UH3CA260318-04
Project IDNIH-10933537 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are individuals who have been diagnosed with sarcoma and are currently surviving post-treatment.

Less likely to help

Patients with sarcoma who are currently undergoing treatment or have not yet been diagnosed may not benefit from this research.

What this research studies

This research aims to create a comprehensive cohort of sarcoma survivors to investigate their long-term health outcomes, including recurrence, organ toxicity, and quality of life. By collecting detailed information on treatment history, lifestyle factors, and health status, the study will explore how these elements influence survival and overall well-being. Participants will provide biospecimens, such as tumor tissue and blood samples, to help identify genetic and biological factors affecting their health. The goal is to enhance understanding of sarcoma survivorship and improve care for these patients.

Why it matters

Potential benefit: If successful, this research could lead to improved health outcomes and quality of life for sarcoma survivors.

How similar studies have gone: Previous research has successfully established survivor cohorts for other cancer types, indicating the potential for meaningful insights in this area as well.

Where this research is happening

  • Vanderbilt University Medical Center
    Nashville, United States
    Active

Researchers

  • Principal investigator: Friedman, Debra L. — Vanderbilt University Medical Center
  • Study coordinator: Friedman, Debra L.

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.